"Ping-pong" fracture: An exclusive entity of neonates and infants? A case analysis and literature review.

Background: "Ping-pong" fractures are a type of depressed fracture in which there is no rupture of the inner or outer table of the skull. It is produced by incomplete bone mineralization. Its appearance is frequent during neonatal and infant ages and is extremely rare outside of these age periods. The objective of this article is to present the case of a 16-year-old patient who presented a "ping-pong" fracture after a traumatic brain injury (TBI) and discuss the underlying physiopathogenesis of these types of fractures. Case Description: A 16-year-old patient presented to the emergency department with a TBI, referring headaches and nausea. Non-contrast brain computed tomography displayed a left parietal "ping-pong" fracture. Laboratory tests showed hypocalcemia, subsequently diagnosing hypoparathyroidism. The patient remained under observation for 48 h. He was managed conservatively and started on calcium carbonate and vitamin D supplements with a favorable evolution. Hospital discharge was granted with TBI discharge instructions and warning signs. Conclusion: The age of presentation of our case was atypical, according to the reported literature. When faced with a "ping-pong" fracture outside of an early age, underlying bone pathologies must be ruled out, which could potentially generate incomplete bone mineralization of the skull.

Effect of Phytase Supplementation on Growth Performance, Mineral Digestibility, and Tibia Calcium and Phosphorous in Broilers Fed Low Phosphorus Diets

The aim of present study was to investigate the effect of phytase supplementation on growth performance, mineral digestibility, and tibia calcium and phosphorous in broilers fed low phosphorus diets. Three hundred broiler chicks were allotted to six different treatments with five replicates each (10 chicks/replicate). T1: Control, 0.5% available phosphorus (Av.P); T2: 0.35P, 0.35% Av.P; T3: 0.20P, 0.20% Av.P; T4: 0.35P-1Phy, diet 0.35P + 1000FTU/kg phytase; T5: 0.20P-2Phy, diet 0.20P + 2000 ftu/kg phytase; T6: 0.20P-3Phy, diet 0.20P + 3000 ftu/kg phytase. Feed intake and weight gain were higher (p=0.001) in broilers fed phytase supplemented diets. Feed conversion ratio was better (p<0.01) in the 0.35P-1Phy than in the others. Calcium and P digestibility was higher (p<0.05) in the 0.35P-1Phy than the 0.35P, 0.20P and 0.20P-2Phy, groups. The highest (p<0.05) tibia ash was observed in the 0.35P and 0.35P-1Phy groups rather than the 0.20P at 21st day, while at 33rd day it was higher (p<0.05) in the control than in 0.20P. At 21st day, tibia Ca content was higher (p<0.05) in the 0.35P-1Phy group as compared to 0.20P and 0.35P, while at 33rd day, tibia Ca content in the control and 0.20P-2Phy groups was higher (p<0.05) than that of 0.20P and 0.35P. Furthermore, tibia P content was higher (p<0.05) in all phytase supplemented groups. It could be concluded that dietary available phosphorus at 0.35% with phytase addition at 1000 FTU/kg reduces the cost per unit weight gain by 9.17%, with positive effects on growth performance.(AU)

Effect of Silicon Carbide Coating on Osteoblast Mineralization of Anodized Titanium Surfaces.

The objective of this study was to evaluate the influence of the titanium nanotube diameter and the effect of silicon carbide (SiC) coating on the proliferation and mineralization of pre-osteoblasts on titanium nanostructured surfaces. Anodized titanium sheets with nanotube diameters of 50 and 100 nm were used. The following four groups were tested in the study: (1) non-coated 50 nm nanotubes; (2) SiC-coated 50 nm titanium nanotubes; (3) non-coated 100 nm nanotubes and (4) SiC-coated 100 nm nanotubes. The biocompatibility and cytotoxicity of pre-osteoblasts were evaluated using a CellTiter-BlueCell Viability assay after 1, 2, and 3 days. After 3 days, cells attached to the surface were observed by SEM. Pre-osteoblast mineralization was determined using Alizarin-Red staining solution after 21 days of cultivation. Data were analyzed by a Kruskal−Wallis test at a p-value of 0.05. The results evidenced biocompatibility and non-cytotoxicity of both 50 and 100 nm diameter coated and non-coated surfaces after 1, 2 and 3 days. The statistical analysis indicates a statistically significant higher cell growth at 3 days (p < 0.05). SEM images after 3 days demonstrated flattened-shaped cells without any noticeable difference in the phenotypes between different diameters or surface treatments. After 21 days of induced osteogenic differentiation, the statistical analysis indicates significantly higher osteoblast calcification on coated groups of both diameters when compared with non-coated groups (p < 0.05). Based on these results, we can conclude that the titanium nanotube diameter did not play any role on cell viability or mineralization of pre-osteoblasts on SiC-coated or non-coated titanium nanotube sheets. The SiC coating demonstrated biocompatibility and non-cytotoxicity and contributed to an increase in osteoblast mineralization on titanium nanostructured surfaces when compared to non-coated groups.

The effects of 1a(OH)D3 individually or in combination with phytase, and different levels of cholecalciferol on performance, tibia criteria, and plasma minerals of Japanese quails

The aim of studywas to compare efficacy of 1-α(OH)D3alone or in combination with phytase and 1-α(OH)D3in combination of phytase and different concentration of cholecalciferol on performance, tibia parameters,andplasma minerals of quails fed Ca-P deficient diet. A total of 280 mixed sex 5-d-old quails were allocated to 7 treatments with 5 replicates.The vitamin supplement which incorporated to basal diet did not contain cholecalciferol.The dietary treatments were as follows: Ca-P deficient diet (basal diet); basal diet + 500 FTU phytase/kg of diet; basal diet + phytase + 5 µg of 1-α(OH)D3kg-1of diet;basal diet + phytase + 5 µg of 1-α(OH)D3and 250, 500, 750 and 1,000 IU of cholecalciferol kg-1of diet. The highest final body weight and the best feed conversion ratioobtained in the group supplemented with 1,000 IU cholecalciferol kg-1of diet (p < 0.05). Supplementation of 1-α(OH)D3 alone or in combination with phytase and phytase and different concentration of cholecalciferol could improve tibia parameters (p < 0.05). In conclusion, supplementation of 1-α(OH)D3alone to Ca-P deficient diet could maximize tibia mineralization, whereas it couldn't maximize performance, performance criteria were maximized by supplementation of 1,000 IU cholecalciferol kg-1of diet.(AU)

Particle size of oyster shell meal and calcium: phosphorus ratios in broiler diets / Efeito do tamanho de partícula da farinha de ostras e relações cálcio: fósforo em dietas para frangos de corte

The effects of Ca:P total ratio and particle size of oyster shell meal (OSM) were evaluated in broiler diets. In Experiment 1, 800 broilers (22-42 days old) were distributed in a 2×2 factorial design, with two Ca:P ratios (1.7 and 2.0:1) and two OSM particle sizes (coarse = 1,354 µm and fine = 428 µm), totaling four treatments with 10 repetitions with 20 broilers. Feed intake, weight gain, and feed conversion ratio were calculated. In Experiment 2, 1,280 broilers were distributed in a 2×2×2 factorial design (1.7 and 2.0:1 Ca:P ratios; coarse and fine OSM; male and female broilers), with eight treatments and 16 repetitions with 10 broilers. Apparent metabolizability of dry matter, Ca, P, and apparent metabolizable energy (AME), as well as bone resistance, bone weight, ash, Ca, and P content in the tibia were assessed. Growth performance was not affected (P > 0.05). Coarse OSM increased tibia Ca content in male broilers (P < 0.001), and higher Ca:P ratio improved bone ash and bone resistance in both sexes (P < 0.001), but reduced P content in male broilers (P < 0.05); male broilers displayed heavier bones with higher ash content than females (P < 0.05). Metabolizability of Ca was improved with coarse OSM (P < 0.05); whereas metabolizability of DM, P, and AME was not affected (P > 0.05). In conclusion, diets with a Ca:P total ratio of 2.0:1 containing coarser OSM improved bone mineral composition, particularly in male broilers, and coarse OSM improved the metabolizability of Ca in broilers regardless of the Ca:P total ratio or broiler sex.

Dois experimentos foram conduzidos para avaliar os efeitos do tamanho de partícula da farinha de ostras (FO) e relação Ca:P total em dietas para frangos de corte. No primeiro experimento, 800 frangos (22 a 42 dias) foram distribuídos em um delineamento fatorial 2x2: 2 relações Ca:P (1,7 e 2,0:1) e dois tamanhos de partícula da FO (grossa = 1354 µm e fina = 428 µm), totalizando quatro tratamentos com 10 repetições de 20 aves. O consumo de ração, o ganho de peso e a conversão alimentar foram calculados. No segundo experimento, 1.280 frangos foram distribuídos em um fatorial 2x2x2 (relações Ca:P 1,7 e 2,0:1; FO grossa e fina; aves machos e fêmeas) com oito tratamentos e 16 repetições de 10 aves. Foram avaliados: metabolizabilidade aparente da matéria seca, Ca e P, energia metabolizável aparente (EMA), peso e resistência óssea, conteúdo de cinzas, Ca e P na tíbia. As variáveis de desempenho não foram afetadas (P > 0,05). O uso de FO grossa aumentou o conteúdo de Ca na tíbia de frangos machos (P < 0,001), e a relação Ca:P de 2,0:1 aumentou o conteúdo de cinzas e aprimorou resistência óssea em ambos os sexos (P < 0,001), porém reduziu P na tíbia dos machos (P < 0,05); frangos machos também tiveram ossos mais pesados e maior conteúdo de cinzas do que fêmeas (P < 0,05). A metabolizabilidade de Ca foi melhorada com FO grossa, enquanto a metabolizabilidade da matéria seca, P, e EMA não foram afetadas (P > 0,05). Conclui-se que as dietas com relação Ca:P de 2,0:1 e com FO grossa resultaram em melhor composição mineral óssea - particularmente em frangos machos - e a FO grossa melhorou a metabolizabilidade de Ca independentemente da relação Ca:P ou do gênero das aves.

Histomorphometry evaluation of bone anabolism promoted by prostaglandin E1 and its relation to hypercalcemia / Evaluación histomorfométrica del anabolismo óseo en la reparación promovida por la prostaglandina E1 y su relación con la hipercalcemia

Abstract Background: At present, parathyroid hormone is the only existing anabolic bone therapy but produces hypercalcemia. Prostaglandin E1 (PGE1) has been suggested as a bone anabolic agent that allows bone modeling formation without producing hypercalcemia. This study aimed to corroborate these PGE1 properties. Methods: For 22 days, rabbits (n = 30) were divided into three groups (n = 10 each group) and received intravenous solutions: vehicle (control group), palate disjunction + vehicle (sham group), and palate disjunction + 50 mg of PGE1 (PGE1 group). On days 1, 3, and 22, palatine suture X-rays were taken. On day 22, bone formation markers were analyzed, and the rabbits were sacrificed. Bone palate undecalcified samples were processed. Histomorphometry software was used to analyze bone parameters, and the mineralization front was stained with toluidine blue. Scalloped lines reflect remodeling-based bone formation (RBF), and smooth lines reflect modeling-based formation (MBF). Results: X-rays showed more significant palatal disjunction in the PGE1 group; this group exhibited significant calcitriol serum increments. Hypercalciuria was observed in the PGE1 group, and resorption markers (N-telopeptides) remained stable. Sutural bones in the PGE1 group exhibited significant anabolism in structural parameters. RBF was 20%, and MBF was 6% in the sham group; in the PGE1 group, RBF was 8.6%, and MBF was 17%. In the PGE1 group, mineralization was significantly accelerated, but resorption remained stable. Conclusions: This model suggests that PGE1 favors palate disjunction, calcitriol synthesis, and shortens the mineralization. Therefore, PGE1 is an important bone anabolic molecule predominantly of modeling-based form and no hypercalcemia.

Resumen Introducción: La hormona paratiroidea es la única molécula anabólica ósea, pero ocasiona hipercalcemia. La prostaglandina E1 (PGE1) sugiere ser un anabólico óseo con formación por modelación predominante y generalmente no ocasiona hipercalcemia. El objetivo de este estudio fue corroborar estas propiedades de la PGE1. Métodos: Por 22 días, 30 conejos divididos en tres grupos (n = 10 cada grupo) recibieron una solución por vía intravenosa: vehículo (grupo control), disyunción palatina más vehículo (grupo sham) y disyunción palatina más 50 mg de PGE1 (grupo PGE1). A los días 1, 3 y 22 se obtuvieron radiografías de la sutura palatina. En el día 22 se analizaron los marcadores bioquímicos de formación ósea y se sacrificó a los conejos. Las suturas y los huesos suturales se procesaron sin descalcificar. La evaluación histomorfométrica fue digitalizada y el frente de mineralización ósea se tiñó con azul de toluidina. Las líneas irregulares reflejan resorción (remodelación) y las líneas rectas no resorción (modelación). Resultados: Radiográficamente, la disyunción palatina fue mayor en el grupo PGE1. Este grupo mostró una hipercalcitonemia significativa, pero la calcemia y los marcadores resortivos (N-telopéptidos) se mantuvieron estables. Por histomorfometría, los huesos suturales del grupo PGE1 mostraron anabolismo significativo en parámetros estructurales. En el grupo sham, la remodelación ósea fue del 20% y la modelación fue del 6%; en el grupo PGE1, la remodelación fue del 8.6% y la modelación fue del 17%. En este mismo grupo, la mineralización fue significativamente acelerada, pero la resorción se mantuvo igual. Conclusiones: Este modelo sugiere que la PGE1 favorece la disyunción palatina y el aumento del calcitriol, y acelera la mineralización y el anabolismo óseo por modelación predominante sin hipercalcemia.

Histomorphometry evaluation of bone anabolism promoted by prostaglandin E1 and its relation to hypercalcemia.

BACKGROUND: At present, parathyroid hormone is the only existing anabolic bone therapy but produces hypercalcemia. Prostaglandin E1 (PGE1) has been suggested as a bone anabolic agent that allows bone modeling formation without producing hypercalcemia. This study aimed to corroborate these PGE1 properties. METHODS: For 22 days, rabbits (n = 30) were divided into three groups (n = 10 each group) and received intravenous solutions: vehicle (control group), palate disjunction + vehicle (sham group), and palate disjunction + 50 µg of PGE1 (PGE1 group). On days 1, 3, and 22, palatine suture X-rays weretaken. On day 22, bone formation markers were analyzed, and the rabbits were sacrificed. Bone palate undecalcified samples were processed. Histomorphometry software was used to analyze bone parameters, and the mineralization front was stained with toluidine blue. Scalloped lines reflect remodeling-based bone formation (RBF), and smooth lines reflect modeling-based formation (MBF). RESULTS: X-rays showed more significant palatal disjunction in the PGE1 group; this group exhibited significant calcitriol serum increments. Hypercalciuria was observed in the PGE1 group, and resorption markers (N-telopeptides) remained stable. Sutural bones in the PGE1 group exhibited significant anabolism in structural parameters. RBF was 20%, and MBF was 6% in the sham group; in the PGE1 group, RBF was 8.6%, and MBF was 17%. In the PGE1 group, mineralization was significantly accelerated, but resorption remained stable. CONCLUSIONS: This model suggests that PGE1 favors palate disjunction, calcitriol synthesis, and shortens the mineralization. Therefore, PGE1 is an important bone anabolic molecule predominantly of modeling-based form and no hypercalcemia.

Vitamin K role in mineral and bone disorder of chronic kidney disease.

Vitamin K is a key cofactor for the activation of proteins involved in blood coagulation, apoptosis, bone mineralization regulation, and vessel health. Scientific evidence shows an important role of activated osteocalcin and matrix-Gla protein in bone and vessels, markedly affected along the course of chronic kidney disease (CKD). In fact, CKD corresponds to an unique condition of vitamin K deficiency caused by dietary restriction, intestinal dysfunction, and impaired vitamin K recycling. Clinical data suggest that vitamin K status can be modulated and this prompts us to speculate whether patients with CKD might benefit from vitamin K supplementation. However, as important as whether the improvement in vitamin K status would be able to result in better bone quality, less vascular calcification, and lower mortality rates, several issues need to be clarified. These include better standardized methods for measuring vitamin K levels, and definition of the optimal concentration range for supplementation in different subgroups. Here, we review the literature data concerning the impact of vitamin K deficiency and supplementation on CKD-associated mineral and bone disorders (CKD-MBD). We present and discuss the available evidence from basic science and clinical studies, and highlight perspectives for further research.

Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis.

BACKGROUND: Polycystic ovary syndrome (PCOS) has reproductive and metabolic aspects that may affect bone health. Controversial results from different studies regarding the risk of fractures, bone mineral density (BMD) or bone markers led to uncertainty whether PCOS might improve or deteriorate bone health. OBJECTIVE AND RATIONALE: This study aimed to investigate the impact of PCOS on bone markers, BMD and fracture risk. SEARCH METHODS: A systematic review and a meta-analysis were carried out. PubMed, EMBASE and Cochrane databases were searched for eligible studies from 1st of January of 1990 to 9th of October of 2018. Eligible studies enrolled women older than 18 years with PCOS, which should be diagnosed according to the Rotterdam Consensus, the Androgen Excess Society, the National Institutes of Health Consensus or the International Classification of Diseases. The studies were grouped according to patient mean BMI: <27 kg/m2 or ≥27 kg/m2. The results were polled as mean difference (MD), standardized MD (SMD) and hazard ratio (HR). OUTCOMES: Overall, 921 studies were retrieved, and 31 duplicated studies were removed. After screening the titles and abstracts, 80 studies were eligible for full text reading. Of those, 23 studies remained for qualitative synthesis. With the exception of one study, all studies were considered high quality based on the Newcastle-Ottawa scale (NOS; score ≥6). Meta-analysis was performed in 21 studies, with a total of 31 383 women with PCOS and 102 797 controls. Women with PCOS with BMI <27 kg/m2 had lower BMD of the total femur (MD, -0.04; 95% CI, -0.07 to 0.00; I2 = 31%; P = 0.22) and spine (MD, -0.07; 95% CI, -0.13 to -0.01; I2 = 70%; P < 0.01) when compared with the control group, whereas for women with BMI ≥27 kg/m2 no difference was observed (femur: MD, 0.02; 95% CI, -0.02 to 0.05; I2 = 20%, P = 0.29; spine: MD, 0.02; 95% CI, -0.06 to 0.05; I2 = 0%; P = 0.84). Osteocalcin was remarkably reduced in women with PCOS with BMI <27 kg/m2 (SMD, -2.68; 95% CI, -4.70 to -0.67; I2 = 98%; P < 0.01), but in women with BMI ≥27 kg/m2, there were no differences between PCOS and controls. Few studies (n = 3) addressed the incidence of bone fractures in women with PCOS. The HR for total bone fractures did not identify differences between women with PCOS and controls. WIDER IMPLICATIONS: On the basis of the available evidence, it is possible to assume that PCOS in women with BMI <27 kg/m2 is associated with reduced BMD in the spine and femur, and decreased bone formation, as manifested by lower levels of circulating osteocalcin. These findings suggest that bone parameters in PCOS may be linked, to some extent, to adiposity. These studies included premenopausal women, who have already achieved peak bone mass. Hence, further prospective studies are necessary to clarify the existence of increased risk of fractures in women with PCOS.

Reduction of calcium levels in rations supplemented with vitamin D3 or 25-OH-D3 for broilers

An experiment was carried out to verify the response to the Ca reduction levels of diets with different vitamin D sources on performance, bone mineral deposition, serum concentrations, digestibility, carcass characteristics, and meat quality of broiler chickens in the period from 1 to 42 days reared in thermoneutral environment. A total of 504 male broilers with one day of age and average weight of 43.27±1.08 g were housed in climatic chambers and distributed in a completely randomized design. The study consisted of a 4 × 2 factorial, with four Ca reduction levels (0, 10, 20, and 30%) and two vitamin D sources (2760 IU of D3 or 25-OH-D3). The performance of animals at 21 and 42 days of age was not affected by Ca reduction by up to 30%, regardless of the vitamin source used. Dietary reduction from 10% decreased serum Ca concentrations. The use of vitamin D3 provided a serum P level greater than the 25-OH-D3. Calcium reduction decreased serum 25-OH-D3 levels. No effect of vitamin source or Ca levels on broiler carcass characteristics was observed at 42 days. The vitamin source did not influence meat quality, while Ca reduction of the diet provided lower losses by thawing and cooking and higher initial pH values. The b* color was reduced in diets with lower Ca levels of the diet. Reducing Ca up to 30% does not affect the performance and carcass characteristics, regardless of the vitamin D source used. The quality of broiler meat is improved with the Ca reduction in the diet, but the vitamin used has no effect on such characteristics. We can conclude, based on the results of performance, blood, and bone, that the performance variables are not adequate to determine the actual requirement of Ca, since as it is a priority to maintain performance, bone mineral mobilization occurs, which may compromise the carcass quality of the birds.(AU)

Influence of dietary 1alpha-hydroxycholecalciferol, individually or in combination with microbial phytase in calcium and phosphorus deficient diets on growth performance and tibia parameter of Japanese quails (Coturnix japonica)

The effect of 1-OH-D3 in calcium-phosphorus (Ca-P) deficient diets on Japanese quail growth performance and tibia parameters was investigated. Eight-day-old (n = 160) newly hatched quails were weighed and randomly allocated to 20 groups, each with 4 replicate pens of 8 birds. Treatments were as follows: T1, Ca-P-adequate; T2,Ca-P-deficient; T3, Ca-P-deficient + 500 FTU kg-1 of phytase (Ph); T4, Ca-P-deficient diet + 5 µg kg-1 of 1-OH-D3; T5,Ca-P-deficient + Ph + 5 µg kg-1 of 1-OH-D3. Results showed that quails fed Ca-P-adequate had significantly higher body weight compared with quails fed Ca-P-deficient, Ca-P deficient supplemented with 1-OH-D3 and Ca-P-deficient supplemented with 1-OH-D3 and phytase, but did not differ from Ca-P-deficient diet supplemented with phytase. Quails fed Ca-P deficient were unable to achieve FCR comparable to quails fed Ca-P-adequate (p 0.05). The percentage of bone ash data indicated that quails fed Ca-P-adequate had higher tibia ash compared with other groups except for quails fed Ca-P deficient diet supplemented with combination of 1-OH-D3 and phytase. Quails fed Ca-P-adequate had higher tibia P compared with quails fed Ca-P-deficient. In conclusion, these results indicated that quails fed Ca-P-deficient supplemented with 5 µg kg-1 of 1-OH-D3 in combination of 500 FTU kg-1 of phytase were able to achieve the same tibia ash and Ca compared with quails fed Ca-P-adequate.

Influence of dietary 1alpha-hydroxycholecalciferol, individually or in combination with microbial phytase in calcium and phosphorus deficient diets on growth performance and tibia parameter of Japanese quails (Coturnix japonica)

The effect of 1-OH-D3 in calcium-phosphorus (Ca-P) deficient diets on Japanese quail growth performance and tibia parameters was investigated. Eight-day-old (n = 160) newly hatched quails were weighed and randomly allocated to 20 groups, each with 4 replicate pens of 8 birds. Treatments were as follows: T1, Ca-P-adequate; T2,Ca-P-deficient; T3, Ca-P-deficient + 500 FTU kg-1 of phytase (Ph); T4, Ca-P-deficient diet + 5 µg kg-1 of 1-OH-D3; T5,Ca-P-deficient + Ph + 5 µg kg-1 of 1-OH-D3. Results showed that quails fed Ca-P-adequate had significantly higher body weight compared with quails fed Ca-P-deficient, Ca-P deficient supplemented with 1-OH-D3 and Ca-P-deficient supplemented with 1-OH-D3 and phytase, but did not differ from Ca-P-deficient diet supplemented with phytase. Quails fed Ca-P deficient were unable to achieve FCR comparable to quails fed Ca-P-adequate (p 0.05). The percentage of bone ash data indicated that quails fed Ca-P-adequate had higher tibia ash compared with other groups except for quails fed Ca-P deficient diet supplemented with combination of 1-OH-D3 and phytase. Quails fed Ca-P-adequate had higher tibia P compared with quails fed Ca-P-deficient. In conclusion, these results indicated that quails fed Ca-P-deficient supplemented with 5 µg kg-1 of 1-OH-D3 in combination of 500 FTU kg-1 of phytase were able to achieve the same tibia ash and Ca compared with quails fed Ca-P-adequate.(AU)

Inadequate Dietary Phosphorus Levels Cause Skeletal Anomalies and Alter Osteocalcin Gene Expression in Zebrafish.

Phosphorus (P) is an essential mineral for the development and maintenance of the vertebrate skeletal system. Modulation of P levels is believed to influence metabolism and the physiological responses of gene expression. In this study, we investigated the influence of dietary P on skeletal deformities and osteocalcin gene expression in zebrafish (Danio rerio), and sought to determine appropriate levels in a diet. We analyzed a total of 450 zebrafish within 31 days of hatching. Animals were distributed in a completely randomized experimental design that consisted of five replications. After an eight-week experiment, fish were diaphanized to evaluate cranial and spinal bone deformities. Increases in dietary phosphorus were inversely proportional to the occurrence of partial spine fusions, the absence of spine fusions, absence of parallelism between spines, intervertebral spacing, vertebral compression, scoliosis, lordosis, ankylosis, fin caudal insertion, and craniofacial deformities. Additionally, osteocalcin expression was inversely correlated to P levels, suggesting a physiological recovery response for bone mineralization deficiency. Our data showed that dietary P concentration was a critical factor in the occurrence of zebrafish skeletal abnormalities. We concluded that 1.55% P in the diet significantly reduces the appearance of skeletal deformities and favors adequate bone mineralization through the adjustment of osteocalcin expression.

Non-phytate phosphorus requirement for broilers from 8 to 21 days of age under heat stress conditions.

Two trials were conducted to determine the non-phytate phosphorus (nPP) requirement for broiler under heat stress. In both trials, birds were distributed in a completely randomized 4 × 2 factorial design with four nPP concentrations: 0.25, 0.35, 0.45, and 0.55%, and two Ca supply techniques: Ca fixed at 0.899% (CaF) or varying along with nPP aiming a 2:1 Ca to nPP ratio (CaV). Both trials had eight pens/treatment, with nine and five birds/pen for exp. 1 and exp. 2, respectively. nPP concentration had no effect on feed intake (FI), body weight gain (BWG), feed conversion ratio (FCR), nor fat deposition ratio (FDR). nPP levels showed a linear effect on protein deposition ratio (PDR) only for CaF diets. The nPP levels had a significant effect, regardless the technique adopted, on tibia phosphorus (TibP), which varied quadratically, on tibia calcium (TibCa) that increased quadratically and linearly, respectively, on CaF and CaV diets, and on tibia ash (TibAsh) that showed a quadratic effect for both. No effect was observed on Ca to P ratio in the tibia (TibCa:TibP). The nPP levels showed a linear increase effect over phosphorus intake (PI), phosphorus excreted (PE), and phosphorus retained (PR), and a linear decrease effect on phosphorus retention coefficient (PRC). Therefore, the nPP requirement for broilers from 8 to 21 days of age that provided better performance and bone variables were 0.250 and 0.484%, respectively, for CaF diets and 0.250 and 0.511%, respectively, for CaV diets.

Maternal Obesity, 25-Hydroxy Vitamin D Concentration, and Bone Density in Breastfeeding Dyads.

OBJECTIVE: To examine the association between maternal body mass index (BMI) and serum 25-hydroxy vitamin D [25(OH)D] concentration and bone density in mother-infant pairs. STUDY DESIGN: The study was a secondary analysis of 234 exclusively breastfeeding dyads who were recruited in the first postpartum month for a randomized controlled trial of maternal vs infant vitamin D supplementation. Mean 25(OH)D concentrations and bone mineral density (BMD) were compared by BMI group. The adjusted association between maternal BMI and 25(OH)D and bone density was examined at 1, 4, and 7 months postpartum. RESULTS: Obese breastfeeding women had lower 25(OH)D concentrations and higher BMD than lean women at all 3 time points (P < .01). Higher maternal BMI was associated with lower maternal serum levels of 25(OH)D at 1, 4, and 7 months postpartum (adjusted ß = -0.45 ng/ml per kg/m2, 95% CI -.076, -0.14, at 1 month) and higher BMD at the same time points (ß = 0.006 BMD z score; 95% CI 0.003, 0.01 at 1 month). Seventy-six percent of infants were vitamin D deficient at 1 month of age. Infants born to overweight and obese mothers had lower 25(OH)D concentrations than infants of lean mothers (P < .01). For infants in the maternal supplementation group, higher maternal BMI was associated with lower 25(OH)D concentrations at 4 months (ß = -0.68; 95% CI -1.17, -0.20) and lower bone density at 7 months (ß = -0.001; 95% CI -0.002, -0.0001). CONCLUSIONS: In exclusively breastfeeding dyads, maternal obesity is associated with lower maternal and infant serum 25(OH)D concentrations, which may impact infant bone density. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00412074.

Bone characteristics of pigs fed different sources of phosphorus / Características óseas de cerdos alimentados con diferentes fuentes de fósforo / Características ósseas de suínos alimentados com diferentes fontes de fósforo

Summary Background: phosphorus supplementation should help to keep bone integrity and prevent fractures during the development and slaughter of animals. Objective: to evaluate the effect of different phosphorus sources on one characteristics of pigs. Methods: one-hundred and twelve piglets (28.65 ± 2.82 Kg body weight) were distributed into an 8×2 factorial arrangement (eight sources of phosphorus × two sexes) in blocks in a completely randomized design. The diets were formulated on a total-phosphorus basis, with 0.32 and 0.31% of P for the control diet and 0.56 and 0.42% of P for the other treatments in the growth and finishing phases, respectively. Phosphorus was supplemented as dicalcium phosphate (DCP); mono-dicalcium phosphate (MDCP); triple superphosphate (TSP); single superphosphate (SSP); Catalão-rock phosphate (ROCK); a mixture of sources (MIX); phosphoric acid (PPA); and the control diet (CTR). Results: there was no interaction between phosphorus sources and sex in any of the parameters. Thickness of the compact tissue was the lowest in the CTR, differing from the diets containing DCP, MDCP, and PPA, followed by diets SSP, TSP, and ROCK, with the greatest value for MDCP. Porosity of the compact tissue was higher for the CTR and SSP diets. Conclusion: the use of less elaborate sources of phosphorus, such as rock phosphate and single superphosphate, was less effective than the other sources to improve bone integrity of pigs.

Resumen Antecedentes: la suplementación dietaria con fósforo ayuda a mantener la integridad del hueso y prevenir fracturas durante el desarrollo y sacrificio de los animales. Objetivo: evaluar el efecto de diferentes fuentes de fósforo sobre las características óseas de los cerdos. Métodos: ciento doce lechones (peso corporal: 28,65 ± 2,82 Kg) se distribuyeron en un arreglo factorial 8×2 (ocho fuentes de fósforo × dos sexos) en bloques al azar. Las dietas se formularon con base en fósforo total, con 0,32 y 0,31% de P para la dieta control y 0,56 y 0,42% de P para los otros tratamientos en las fases de crecimiento y finalización, respectivamente. El fósforo se suplementó como fosfato dicálcico (DCP), monofosfato dicálcico (MDCP), superfosfato triple (TSP), superfosfato simple (SSP), fosfato de roca Catalão (ROCK), mezcla de fuentes (MIX), ácido fosfórico (PPA) y dieta control (CTR). Resultados: no se observó interacción entre las fuentes de fósforo y el sexo en ninguno de los parámetros estudiados. El espesor del tejido compacto fue más bajo en el CTR, y diferente a las dietas que contenían DCP, MDCP y PPA, seguido por las dietas SSP, TSP y ROCK; con el mayor valor para MDCP. La porosidad del tejido compacto fue mayor para las dietas CTR y SSP. Conclusión: el uso de fuentes menos elaboradas de fósforo, tales como el fosfato de roca y superfosfato simple, fue menos efectivo que las otras fuentes en mejorar la integridad ósea de los cerdos.

Resumo Antecedentes: a suplementação de fósforo deve manter a integridade do tecido ósseo e prevenir fraturas durante o desenvolvimento e abate dos animais. Objetivo: avaliar o efeito de diferentes fontes de fósforo sobre as características ósseas dos suínos. Métodos: cento e doze leitões com peso médio inicial de 28,65 ± 2,82 Kg foram distribuídos em esquema fatorial 8×2 (oito fontes de fósforo × dois sexos) em blocos casualizados. As dietas foram formuladas baseadas em fósforo total com 0,32 e 0,31% de P para a dieta controle e com 0,56 e 0,42% de P para os outros tratamentos nas fases de crescimento e terminação, respectivamente. O fósforo nas dietas foi suplementado com fosfato bicálcico (DCP); mono-fosfato bicálcico (MDCP); superfosfato triplo (TSP); superfosfato simples (SSP); fosfato de rocha Catalão (ROCK); uma mistura de fontes (MIX); ácido fosfórico (PPA); e a dieta controle (CTR). Resultados: não houve interação entre as fontes de fósforo e sexo dos animais para qualquer um dos parâmetros estudados. A espessura do tecido compacto é menor na CTR, diferenciando-se das dietas DCP, MDCP e PPA, seguido pelas dietas SSP, TSP e ROCK, sendo que o maior valor foi observado na dieta com MDCP. A porosidade do tecido compacto foi maior com as dietas CTR e SSP. Conclusão: o uso de fontes menos elaboradas de fósforo como superfosfato simples e fosfato de rocha foram menos eficientes do que os outros tratamentos para melhorar a integridade óssea de suínos.

Evaluation of using two metabolites of Vitamin D3 with phytase in the diet of laying hens finishing their productive cycle / Evaluación del empleo de dos metabolitos de vitamina D3 con fitasa en la dieta de gallinas ponedoras finalizando el ciclo productivo / Avaliação da utilização de dois metabolitos da vitamina D3 com fitasse na dieta de galinhas poedeiras finalizando o ciclo produtivo

The effect of supplementing the diet with two sources of vitamin D3, 1α-hidroxycholecalciferol (1α-OH-D3) and 25-hidroxycholecalciferol (25-OH-D3), in the presence of phytase, on the productive indicators, the bone mineral composition and the external quality of the eggs of comercial laying hens during weeks 55 to 68 of life. A total of 360 Lohman Brown hens were used, distributed between four treatments with six replicates per treatment and 15 birds per replicate. The diets were: T1 (diet with 50g ton-1 of phytose), T2 (same as T1 plus 12.5g ton-1 of 1α-OH-D3 without considering the phosphorus and calcium contributions), T3 (same as T1 with the addition of 12. 5g ton-1 considering a liberation of 0.05% of available phosphorus and calcium ), and T4 (same as T1 with the addition of 5.52g ton-1 of 25-OH-D3 considering a liberation of 0.05% of available phosphorus and calcium). All birds had free Access to wáter and food according to recomendations for comercial lines. The variables laying percentage, cumulative conversión, egg quality, Shell minerals, percentage of Shell in the egg, egg density, and bone minerals were not significantly influenced (p>0.05) by the source or type of inclusión of vitamin D3. However, the use of vitamin 1α-OH-D3 in a matrix showed a net economic benefit, representing the lowest production cost and highest income for egg sales. In future research with laying hens, it is necessary to check the level of inclusión of vitamin D3 as well as the concentration of calcium in the diet.

Se evaluó el efecto de la suplementación de dos fuentes de vitamina D3 , 1α-hidroxicolecalciferol (1α-OH-D3,) y 25-hidroxicolecalciferol (25-OH-D3 ), en la presencia de fitasa, sobre los indicadores productivos, la composición mineral ósea y la calidad externa del huevo de gallinas de postura comercial durante las semanas 55 a la 68 de vida Se utilizaron 360 gallinas Lohmann Brown, distribuidas entre cuatro tratamientos con seis réplicas por tratamiento y quince aves por replica. Las dietas fueron: T1 (dieta con 50 g ton-1 de fitasa), T2 (igual a T1 más la adición de 12,5 g ton-1 de 1α-OH-D3 sin valorar los aportes de calcio y fósforo), T3 (igual a T1 con la adición de 12,5 g ton-1 de 1α-OH-D3 considerando una liberación de 0,05% del fósforo y calcio disponible), T4 (igual a T1 con la adición de 5,52 g ton-1 de 25-OH-D3 considerando una liberación de 0,05% del fósforo y calcio disponible). Todas las aves tuvieron acceso a agua y alimento de acuerdo a la recomendación para la línea comercial. Las variables porcentaje de postura, conversión acumulada, calidad de huevo, minerales en cáscara, % de cáscara en huevo, densidad de huevos y minerales en huesos no fueron influenciadas significativamente (p>0,05) por la fuente ni el tipo de inclusión de la vitamina D3 . Sin embargo, el uso de la vitamina 1α-OH-D3 matrizada mostró un beneficio económico neto, representado en menor costo de producción y mayor ingreso por ventas de huevo. En futuras investigaciones con ponedoras, es necesario verificar tanto el nivel de inclusión de vitamina D3 como la concentración de calcio de la dieta..

Avaliou-se o efeito da suplementação de dois fontes de vitamina D3 , 1α-hidroxicolecalciferol (1α-OH-D3,) e 25-hidroxicolecalciferol (25-OH-D3 ), na presença de fitasse sobre os indicadores produtivos, a composição mineral óssea e a qualidade externa do ovo de galinhas poedeiras comerciais entre as semanas 55 e 68. Utilizaram-se 362 galinhas Lohman Brown, distribuídas em quatro tratamentos com seis réplicas por tratamento e 15 aves por replica. As dietas foram: T1 (dieta com 50 g ton-1 de fitasse), T2 (igual a T1 mais a adição de 12,5 g ton-1 de 1α-OH-D3 sem valorar os aportes de cálcio e fósforo), T3 (igual a T1 com a adição de 12,5 g ton-1 de 1α-OH-D3 considerando uma liberação de 0,05% de fósforo e cálcio disponível), T4 (igual a T1 com a adição de 5,52 g ton-1 de 25-OH-D3 considerando uma liberação de 0,05% do fósforo e cálcio disponível). Todas as aves tiveram aceso a agua e alimento de acordo a recomendação para linha comercial. As variáveis: porcentagem de postura, conversão acumulada, qualidade do ovo, minerais em casca, % de casca em ovo, densidade do ovo e minerais em ossos não foram influenciadas significativamente (p>0,05) pela fonte nem pelo tipo de inclusão de vitamina D3 . Embora, a utilização da vitamina 1α-OH-D3 matrizada mostrou um benefício económico neto, representado pelo menor custo de produção e maior ingresso por ventas de ovos. Em futuras pesquisas com poedeiras, é necessário verificar tanto o nível de inclusão de vitamina D3 quanto a concentração de cálcio na dieta..

Enzyme Supplementation of Broiler Feeds with Reduced Mineral and Energy Levels

An experiment was conducted with the purpose of evaluatingenzyme blends on the performance, carcass traits, and bonemineralization of broilers. In total, 928 one-day-old Cobb 500 malechicks of were used. A completely randomized design with fourtreatments with eight replicates of 29 birds each was adopted. Theevaluated treatments were: 1- Positive Control (PC), feed containingthe nutritional recommendations of the genetic companys manual; 2-Negative Control (NC), feed with reductions of 75 kcal/kg AME and0.10 and 0.12 percent points of phosphorus and calcium, respectively;3 - NC + enzyme blend (amylase + β-glucanase, xylanase, and phytase;250 g/t of feed) and 4 - NC + enzyme complex (phytase, amylase,xylanase, glucanase, pectinase, cellulase, and protease; 200 g/t offeed). Birds fed the diet with reduced nutrient levels (NC) presentedthe worst performance (p<0.05). The supplementation of the enzymeblend promoted similar (p<0.05) weight gain and feed conversion ratioas those obtained with the PC diet during the period of 1-21 daysof age. During the phase of 22-42 days and the entire experimentalperiod, weight gain and feed conversion ratio improved with the use ofthe enzyme combinations compared with the NC group, but remainedlower than the PC group. Enzymes combinations did not affect (p>0.05)carcass or parts yields. The broilers fed the reduced-nutrient and energydiet presented lower (p<0.05) tibial ash, calcium, and phosphoruscontents that the other treatments. The use of enzyme combinationsimproved the performance of broilers fed diets with reduced nutrientand energy levels.(AU)

Enzyme Supplementation of Broiler Feeds with Reduced Mineral and Energy Levels

An experiment was conducted with the purpose of evaluatingenzyme blends on the performance, carcass traits, and bonemineralization of broilers. In total, 928 one-day-old Cobb 500 malechicks of were used. A completely randomized design with fourtreatments with eight replicates of 29 birds each was adopted. Theevaluated treatments were: 1- Positive Control (PC), feed containingthe nutritional recommendations of the genetic company’s manual; 2-Negative Control (NC), feed with reductions of 75 kcal/kg AME and0.10 and 0.12 percent points of phosphorus and calcium, respectively;3 - NC + enzyme blend (amylase + β-glucanase, xylanase, and phytase;250 g/t of feed) and 4 - NC + enzyme complex (phytase, amylase,xylanase, glucanase, pectinase, cellulase, and protease; 200 g/t offeed). Birds fed the diet with reduced nutrient levels (NC) presentedthe worst performance (p0.05)carcass or parts yields. The broilers fed the reduced-nutrient and energydiet presented lower (p<0.05) tibial ash, calcium, and phosphoruscontents that the other treatments. The use of enzyme combinationsimproved the performance of broilers fed diets with reduced nutrientand energy levels.

Avaliação funcional de implantes por mineralização óssea in vitro / Functional evaluation of implants by bone mineralization in vitrot

A evolução do projeto dos implantes osseointegráveis é resultado do desenvolvimento de diferentes tipos de estruturas em sua superfície. No entanto, ainda existe a necessidade de estudos para definir o tipo de superfície ideal. Esse trabalho discute métodos de avaliação da superfície de implantes que mostram o potencial de determinadas superfícies para induzir mineralização óssea in vitro, partir do uso de células mesenquimais progenitoras. Foram realizadas análises comparativas entre a topografia de implantes com e sem rugosidades nanométricas e o tipo de interação entre pré-osteoblastos semeados diretamente nesses implantes. Características distintas foram observadas em cada superfície.

Improvements in dental implants structure is the result of development of different types of geometrically intelligent surfaces, provided by the emergence of companies interested in innovation of these materials, however, there is still a need for studies to define the type of ideal surface. This work addresses an unprecedented discussion regarding implant surface evaluation methods, able to show the potential of certain areas to induce bone mineralization in vitro. From the use of mesenchymal progenitor cells, which have the capacity to respond to stimuli surface, comparative tests were performed between the topography implants with and without nano-roughness and the type of functional interaction between pre-osteoblasts seeded directly into these implants. Different characteristics of coating cells and mineralization niches on different surfaces were found.